Conditions:  Locally Advanced Pancreatic Carcinoma;  Metastatic Pancreatic Carcinoma;  Recurrent Pancreatic Carcinoma;  Stage III Pancreatic Cancer AJCC v8;  Stage IV Pancreatic Cancer AJCC v8
Interventions: Â Drug:Â Binimetinib; Â Drug:Â Encorafenib
Sponsors:  Academic and Community Cancer Research United;  National Cancer Institute (NCI)
**RECRUITING NOW**
Interventions: Â Drug:Â Binimetinib; Â Drug:Â Encorafenib
Sponsors:  Academic and Community Cancer Research United;  National Cancer Institute (NCI)
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
